ReqMed

ReqMed is a pharmaceutical company that was founded in 2010 and focuses on the development and commercialization of drugs for the treatment of autoimmune diseases. They have a strong focus on developing biologic drugs targeting specific molecular pathways involved in inflammatory and autoimmune disorders. ReqMed's portfolio includes drugs for rheumatoid arthritis, psoriasis, multiple sclerosis, and other related conditions. Their research and development efforts are centered on advancing innovative treatment options for patients with these diseases.